A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations
Clinical trial NCT01342965 · COMPLETED
Trial details
- NCT number
- NCT01342965
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-07-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.